SCHEMBL13474765

SCHEMBL13474765

C[C@]1(N)CC[C@H]2[C@@H]3CC4(CC4)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 8/20 0.66
▸ AR P10275 7/20 0.66
▸ CYP3A4 P08684 3/20 0.46
▸ ABCB11 O95342 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ NR3C1 P04150 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ ESR1 P03372 1/20 0.46
▸ SHBG P04278 1/20 0.46
▸ ADRA2A P08913 1/20 0.46
▸ SLC6A4 P31645 1/20 0.46
▸ NR3C2 P08235 2/20 0.45
▸ CYP19A1 P11511 2/20 0.42
▸ MAPT P10636 2/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ CHRM1 P11229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4214412 0.83 PGR (0.62) PGRARCYP3A4ABCB11LMNA
SCHEMBL12949518 0.81 PGR (0.66) PGRARCYP3A4ABCB11LMNA
SCHEMBL13062432 0.80 PGR (0.62) PGRARCYP3A4ABCB11LMNA
SCHEMBL13013558 0.80 AR (0.73) PGRARNR3C2
SCHEMBL12924059 0.79 PGR (1.00) PGRARNR3C2
SCHEMBL12923954 0.79 PGR (1.00) PGRARNR3C2
SCHEMBL13334773 0.79 AR (0.54) PGRARCYP3A4LMNAHIF1A
SCHEMBL13770741 0.79 PGR (0.57) PGRARCYP3A4ABCB11LMNA
SCHEMBL985419 0.78 PGR (0.56) PGRARCYP3A4ABCB11LMNA
SCHEMBL4207166 0.74 AR (0.52) PGRARCYP3A4ABCB11LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2170925-B1 17ß -CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE BAYER IP GMBH (DE) 2012-10-24 — — EP disclosed
WO-2008151746-A2 17β-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-18 — — WO disclosed
Send feedback